5
American Academy of Pediatrics Provisional Section on Advances in Therapeutics and Technology (P-SATT)

P-SATT Leadership Team

Embed Size (px)

DESCRIPTION

American Academy of Pediatrics Provisional Section on Advances in Therapeutics and Technology (P-SATT). P-SATT Leadership Team. Charlie Thompson (Chair), MD FAAP Chair, Executive Committee General Pediatrics Medical Director, Pfizer Inc Brahm Goldstein, MD MCR FAAP - PowerPoint PPT Presentation

Citation preview

Page 1: P-SATT Leadership Team

American Academy of PediatricsProvisional Section on Advances in

Therapeutics and Technology(P-SATT)

Page 2: P-SATT Leadership Team

P-SATT Leadership Team• Charlie Thompson (Chair), MD FAAP

– Chair, Executive Committee– General Pediatrics– Medical Director, Pfizer Inc

• Brahm Goldstein, MD MCR FAAP– Member, Executive Committee– Chair, Membership & Communication Subcommittee– Pediatric Critical Care– Senior Medical Director, Ikaria Inc

• Gwen Levy, MD FAAP– Member, Executive Committee– Program Chair, National Conference & Exhibition– General Pediatrics– Global Safety Medical Director– Amgen

• Sam Maldonado, MD FAAP– Chair, Liaison Subcommittee– Pediatric Infectious Diseases– Vice President & Head of Pediatric Drug Development

Center of Excellence, Janssen Pharmacuetical Companies

• Andrew Mulberg, MD FAAP– Member, Executive Committee– Pediatric Gastroenterology– Division Deputy Director, Gastroenterology and Inborn

Errors Products– Food and Drug Administration

• Ron Portman, MD FAAP FASN– Member, Executive Committee– Chair, Government Subcommittee– Pediatric Nephrology– Group Director, Bristol-Myers Squibb

• Chuck Schubert, MD MPH FAAP– Chair, Safety Subcommittee– General Pediatrics– Senior Medical Director, Patient Safety– AstraZeneca

• Stephen Spielberg, MD PhD FAAP– Member, Executive Committee– Chair, Education Subcommittee– Pharmacology– Director, Center for Personalized Medicine and

Therapeutic Innovation , Children's Mercy Hospital

• Seth Toback, MD FAAP– Newsletter Editor & ListServ Moderator– General Pediatrics– Medical Director, MedImmune

• Paul Wang, MD FAAP– Member, Executive Committee– Chair, Research Subcommittee– Behavioral and Developmental Pediatrics– Vice President, Seaside Therapeutics

Page 3: P-SATT Leadership Team

P-SATT Goals and Objectives• Mission

– To advance pediatric health and well-being through collaboration, communication and education on the discovery and development of therapeutics and technology and their successful translation into practice

• Goals– Communication

• To improve communication and relationships with AAP members within industry, academia and government agencies to create opportunity for dialogue with the organizations that employ them

– Education• To educate AAP membership on the discovery, development, and implementation process

for therapeutics and technology– Networking

• To create a vibrant member community and network that will add value to AAP members • To serve as a resource and integrate expertise with other Sections, Committees and

membership-at-large – Integration

• To explore the research and development process and make recommendations that will improve quality, safety, understanding and efficiency

Page 4: P-SATT Leadership Team

P-SATT Proposed 2011 Activities• Communication

– Develop a dialogue with AAP Leadership on potential areas of collaboration between the AAP, industry, academia, and government agencies (e.g., FDA)

• Education– Educate AAP members about drug discovery and development, clinical research and

regulatory issues involving new therapeutics and technology for children• Section education program at 2011 AAP on advancing pediatric medicine

– Educate AAP members about alternative career paths (e.g., industry, government)

• Networking– Develop strategies to recruit AAP members from diverse background into the Section,

connect them to each other, and engage them in a meaningful way in the work of the section

– Develop liaisons with other AAP sections and committees

• Integration– Explore ways to improve the process of drug/device research and development and its

translation to everyday practice– Explore relationships between AAP, industry, academia and government agencies (e.g.,

FDA)

Page 5: P-SATT Leadership Team

How To Join P-SATT• If you are a member of the AAP, please follow the instructions

below to join our section– 1) Follow the link to the AAP Member Center

• http://www.aap.org/moc/memberservices/sectionform.cfm

– 2) Log in as an AAP member– 3) Check the box for “Advances in Therapeutics and Technology” and

complete the remainder of the form.

• If you are not yet an AAP member but are eligible to join, please follow the link below to join the AAP and then follow the section instructions above– http://www.aap.org/member/memcat.htm